Stock Price Quote

PARNAX LAB LTD.

NSE : NABSE : 506128ISIN CODE : INE383L01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE129.00-3 (-2.27 %)
PREV CLOSE ( ) 132.00
OPEN PRICE ( ) 129.50
BID PRICE (QTY) 129.00 (212)
OFFER PRICE (QTY) 132.00 (250)
VOLUME 7456
TODAY'S LOW / HIGH ( )127.15 134.00
52 WK LOW / HIGH ( ) 55167.9
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1982
Management Info
- Chairman Baiju M Shah - Managing Director
Registered Office

Address Gala No 114 , Bldg . No . 8,Jogani Industrial Complex,Chunabhatti,
Mumbai,
Maharashtra-400022

Phone 022 68252525

Email info@naxparlab.com

Website www.naxparlab.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE

NEWS

11Apr Parnax Lab informs about certificate
Parnax Lab has informed that it enclosed the Certificate as per Regulati..
08Apr Parnax Lab informs about confirmation
Parnax Lab has informed that it received confirmation certificate from R..
11Jan Parnax Lab informs about compliance ce
Parnax Lab has informed that it has received confirmation from its Regis..
28Apr Parnax Lab informs about reply to clar
With reference to letter dated April 27, 2023, Parnax Lab has informed t..
06Jul Parnax Lab informs about disclosure
Parnax Lab has informed that the exchange has received the disclosure un..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit9.8612.06
Gross Profit 13.25 16.28
Operating Profit 13.5519.45
Net Sales 27.6874.74

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  3988.75 (3.85%)
M.Cap ( in Cr)105523.76
Astrazeneca Pharma I (BSE)
peergroup  5435.15 (2.55%)
M.Cap ( in Cr)13583.38
Sanofi India (BSE)
peergroup  8252.00 (1.44%)
M.Cap ( in Cr)19090.08
Abbott India (BSE)
peergroup  25827.00 (0.40%)
M.Cap ( in Cr)55141.94
Glaxosmithkline Phar (BSE)
peergroup  2128.00 (3.03%)
M.Cap ( in Cr)35953.04

Shareholding Pattern

PROMOTERS 72.3%
NON-INSTITUTION 27.7%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Parnax Lab Ltd.

Parnax Lab Ltd. was incorporated in the year 1982. Its today's share price is 129. Its current market capitalisation stands at Rs 149.31 Cr. In the latest quarter, company has reported Gross Sales of Rs. 74.74 Cr and Total Income of Rs.78.45 Cr. The company's management includes Harish S Panpalia, Preet Vijay Kukreja, Yogesh Varia, Tirunillai V Anatharaman, Ami M Shah, Baiju M Shah, Prakash M Shah.

It is listed on the BSE with a BSE Code of 506128 , NSE with an NSE Symbol of and ISIN of INE383L01019. It's Registered office is at Gala No 114 , Bldg . No . 8,Jogani Industrial Complex,ChunabhattiMumbai-400022, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are CN Patel & Co, Ladha Singhal & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.